Bristol Myers Squibb (BMY) Free Cash Flow Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
36.22% |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,827.56% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-56.64% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
154.57% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
149.74% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
50.71% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
46.82% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
23.04% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-55.31% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-55.31% |
| Dec 31, 2025 |
-60.50% |
| Sep 30, 2025 |
13.75% |
| Jun 30, 2025 |
72.29% |
| Mar 31, 2025 |
-33.57% |
| Dec 31, 2024 |
3.54% |
| Sep 30, 2024 |
19.46% |
| Jun 30, 2024 |
26.78% |
| Mar 31, 2024 |
-5.27% |
| Dec 31, 2023 |
32.50% |
| Sep 30, 2023 |
28.17% |
| Jun 30, 2023 |
-18.15% |
| Mar 31, 2023 |
-24.36% |
| Dec 31, 2022 |
-20.79% |
| Sep 30, 2022 |
-31.14% |
| Jun 30, 2022 |
-30.21% |
| Mar 31, 2022 |
-2.52% |
| Dec 31, 2021 |
21.65% |
| Sep 30, 2021 |
136.33% |
| Jun 30, 2021 |
-34.66% |
| Mar 31, 2021 |
-2.67% |
| Dec 31, 2020 |
59.17% |
| Sep 30, 2020 |
-10.65% |
| Jun 30, 2020 |
130.55% |
| Mar 31, 2020 |
216.27% |
| Dec 31, 2019 |
-40.89% |
| Sep 30, 2019 |
124.27% |
| Jun 30, 2019 |
120.26% |
| Mar 31, 2019 |
26.71% |
| Dec 31, 2018 |
278.33% |
| Sep 30, 2018 |
-27.29% |
| Jun 30, 2018 |
-35.70% |
| Mar 31, 2018 |
64.21% |
| Dec 31, 2017 |
-19.50% |
| Sep 30, 2017 |
36.50% |
| Jun 30, 2017 |
650.56% |
| Mar 31, 2017 |
221.28% |
| Dec 31, 2016 |
78.96% |
| Sep 30, 2016 |
266.55% |
| Jun 30, 2016 |
289.36% |
| Mar 31, 2016 |
-195.92% |
| Dec 31, 2015 |
57.22% |
| Sep 30, 2015 |
-63.57% |
| Jun 30, 2015 |
-109.94% |
| Mar 31, 2015 |
-1.80% |
| Dec 31, 2014 |
-68.51% |
| Sep 30, 2014 |
-14.32% |
| Jun 30, 2014 |
-33.00% |
| Mar 31, 2014 |
191.90% |
| Dec 31, 2013 |
83.06% |
| Sep 30, 2013 |
-79.11% |
| Jun 30, 2013 |
38.30% |
| Mar 31, 2013 |
-305.68% |
| Dec 31, 2012 |
-53.91% |
| Sep 30, 2012 |
175.53% |
| Jun 30, 2012 |
0.20% |
| Mar 31, 2012 |
-34.98% |
| Dec 31, 2011 |
-2.45% |
| Sep 30, 2011 |
24.73% |
| Jun 30, 2011 |
5.27% |
| Mar 31, 2011 |
21.19% |
| Dec 31, 2010 |
28.05% |
| Sep 30, 2010 |
-0.77% |
